Demystifying Sage Therapeutics: Insights From 5 Analyst Reviews
Demystifying Sage Therapeutics: Insights From 5 Analyst Reviews
揭开Sage疗法的神秘面纱：来自5条分析师评论的见解
During the last three months, 5 analysts shared their evaluations of Sage Therapeutics (NASDAQ:SAGE), revealing diverse outlooks from bullish to bearish.
在过去的三个月中，5位分析师分享了他们对Sage Therapeutics（纳斯达克股票代码：SAGE）的评估，揭示了从看涨到看跌的不同前景。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表总结了他们最近的评估，说明了过去30天不断变化的情绪，并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $26.2, with a high estimate of $29.00 and a low estimate of $22.00. Surpassing the previous average price target of $22.50, the current average has increased by 16.44%.
分析师对12个月目标股价的评估提供了更多见解，显示平均目标价为26.2美元，最高估计为29.00美元，低估值为22.00美元。超过了之前的平均目标价22.50美元，目前的平均价格上涨了16.44％。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：仔细观察
The standing of Sage Therapeutics among financial experts is revealed through an in-depth...
通过对分析师近期行为的深入探...
登录免费看全文
登录/注册